Vickie Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vickie Lee has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Adam Eslick
Department of Anaesthesia, Westmead Hospital, Sydney, NSW, Australia
2 shared publications - Samual Turnbull
Department of Cardiology, Westmead Hospital, Westmead Applied Research Centre, University of Sydney, Westmead, Australia
2 shared publications - Saurabh Kumar
Department of Cardiology, Westmead Hospital, Sydney, Australia
2 shared publications - Timothy Campbell
Department of Cardiology, Westmead Hospital, Westmead Applied Research Centre, University of Sydney, Westmead, NSW, Australia
2 shared publications A. Robert Denniss
Department of Cardiology, Westmead Hospital (K.H., R.G.B., T.C., V.L., S.T., W.W.B.C., S.P.T., A.R.D., C.K.C., S.K.).
1 shared publicationAlfred Hing
Department of cardiothoracic surgery, Westmead Hospital, Sydney, NSW, Australia
1 shared publication
Latest Publications
- 1 December 2022
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 15 (12)
Early Catheter Ablation Versus Initial Medical Therapy for Ventricular Tachycardia Storm
Background: Ventricular tachycardia (VT) storm is associated with significantly increased morbidity, mortality, and exponential healthcare utilization. Although catheter ablation (CA) may be curative, there are limited data directly comparing outcomes of early CA with initial medical therapy. Methods: We compared outcomes of patients presenting with VT storm treated with initial CA versus those treated with initial medical therapy during their first storm presentation in an observational study. Retrospective data from the host institution from January 2014 to April 2020 of 129 patients with their first VT storm presentation were analyzed (58 underwent initial CA, 71 underwent treatment with initial medical therapy). Outcomes were compared in follow-up. Results: Median time to initial CA was 6 days. Over a median follow-up of 702 days, patients who underwent initial CA compared with those treated with initial medical therapy had significantly less: (i) VA recurrence (43% versus 92%; P =0.002); (ii) VT storm recurrence (28% versus 73%; P P =0.002); (iv) iatrogenic complications (at 12 months: 17% versus 45%; P P =0.01); (vi) total number of hospitalizations (median 1 versus 4; P P <0.001). There were no intraprocedural deaths in patients treated with early CA. Conclusion: In an observational setting in which patients presenting with storm, early CA appears superior to initial medical therapy in terms of VT recurrence, storm recurrence, iatrogenic complications, cardiovascular hospitalizations, and cumulative days in hospital in follow-up.
- 1 December 2022
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 15 (12)
Early Catheter Ablation Versus Initial Medical Therapy for Ventricular Tachycardia Storm
Background: Ventricular tachycardia (VT) storm is associated with significantly increased morbidity, mortality, and exponential healthcare utilization. Although catheter ablation (CA) may be curative, there are limited data directly comparing outcomes of early CA with initial medical therapy. Methods: We compared outcomes of patients presenting with VT storm treated with initial CA versus those treated with initial medical therapy during their first storm presentation in an observational study. Retrospective data from the host institution from January 2014 to April 2020 of 129 patients with their first VT storm presentation were analyzed (58 underwent initial CA, 71 underwent treatment with initial medical therapy). Outcomes were compared in follow-up. Results: Median time to initial CA was 6 days. Over a median follow-up of 702 days, patients who underwent initial CA compared with those treated with initial medical therapy had significantly less: (i) VA recurrence (43% versus 92%; P =0.002); (ii) VT storm recurrence (28% versus 73%; P P =0.002); (iv) iatrogenic complications (at 12 months: 17% versus 45%; P P =0.01); (vi) total number of hospitalizations (median 1 versus 4; P P <0.001). There were no intraprocedural deaths in patients treated with early CA. Conclusion: In an observational setting in which patients presenting with storm, early CA appears superior to initial medical therapy in terms of VT recurrence, storm recurrence, iatrogenic complications, cardiovascular hospitalizations, and cumulative days in hospital in follow-up.
- 1 April 2021
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 30 (4) , 555-566
Ventricular Tachycardia Storm Ablation With Pre-Emptive Circulatory Support by Extracorporeal Membrane Oxygenation: Australian Experience
- 1 April 2021
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 30 (4) , 555-566
Ventricular Tachycardia Storm Ablation With Pre-Emptive Circulatory Support by Extracorporeal Membrane Oxygenation: Australian Experience